ARTICLE | Company News
Rigel, Aclaris deal
September 14, 2015 7:00 AM UTC
Rigel granted Aclaris’ Aclaris Therapeutics International Ltd. subsidiary exclusive, worldwide rights to develop and commercialize Rigel’s preclinical JAK inhibitors to treat alopecia areata and othe...